Home LiteratureArticle Details
PMID: 10869234 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.

American journal of human genetics ·Vol. 67 ·No. 2 ·2000-08-00 ·Pages 311-9

Ciotti P, Struewing JP, Mantelli M, Chompret A, Avril MF, Santi PL, Tucker MA, Bianchi-Scarrà G, Bressac-de Paillerets B, Goldstein AM

Abstract

Germline mutations within the coding region of CDKN2A have been observed in affected members of melanoma-prone families. G101W is the most common CDKN2A missense mutation identified to date. It has been reported in several families from around the world, with a particularly high occurrence in France and Italy. Given the frequency of this mutation, we were interested in determining whether the mutation resulted from a single origin or represented a mutational hotspot in the CDKN2A gene. In addition, given the geographical distribution of the mutation, we examined the date of origination of the mutation and its migratory spread. We examined 10 families from Italy, 4 families from the United States, and 6 families from France with the G101W mutation. The following eight markers were employed for the haplotype analysis: IFNA, D9S736, D9S1749, D9S942, D9S1748, D9S1604, D9S171, and D9S126. Our findings showed no significant evidence for mutational heterogeneity, suggesting that all studied families derived from a single ancestral haplotype on which the mutation arose. Using maximum-likelihood methods, we estimated the mutation to have arisen 97 generations ago (1-LOD-unit support interval 70-133 generations) providing some explanation for the wide geographical spread of this common mutation, particularly in southwestern Europe. The presence of a founder mutation in a defined geographic area can facilitate carrier detection and genetic counseling and can provide an opportunity to study disease penetrance and the effect of environmental factors on the background of a common genetic susceptibility.

MeSH Terms
Amino Acid Substitution/genetics Cyclin-Dependent Kinase Inhibitor p16/genetics Female Founder Effect France Gene Frequency/genetics Genetic Heterogeneity Genetic Markers/genetics Genetic Predisposition to Disease/genetics Genotype Germ-Line Mutation/genetics Haplotypes/genetics Humans Italy Likelihood Functions Male Melanoma/genetics Pedigree Time Factors United States
Chemicals
Cyclin-Dependent Kinase Inhibitor p16 Genetic Markers
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Ciotti P
Department of Oncology, Biology and Genetics, University of Genova, Italy.
Struewing J P
Mantelli M
Chompret A
Avril M F
Santi P L
Tucker M A
Bianchi-Scarrà G
Bressac-de Paillerets B
Goldstein A M
References (30)
30 references, click to expand
  1. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
    Nat Genet. 1994 Sep;8(1):23-6 PMID: 7987388
  2. Germline p16 mutations in familial melanoma.
    Nat Genet. 1994 Sep;8(1):15-21 PMID: 7987387
  3. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population.
    Nat Genet. 1995 Feb;9(2):152-9 PMID: 7719342
  4. Mutations associated with familial melanoma impair p16INK4 function.
    Nat Genet. 1995 May;10(1):114-6 PMID: 7647780
  5. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
    N Engl J Med. 1995 Oct 12;333(15):970-4 PMID: 7666916
  6. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.
    N Engl J Med. 1995 Oct 12;333(15):975-7 PMID: 7666917
  7. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.
    Nat Genet. 1995 Jul;10(3):351-3 PMID: 7670475
  8. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.
    Oncogene. 1995 Dec 7;11(11):2289-94 PMID: 8570179
  9. Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds.
    Hum Mol Genet. 1995 Oct;4(10):1845-52 PMID: 8595405
  10. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
    Am J Hum Genet. 1996 Feb;58(2):271-80 PMID: 8571953
  11. Novel germline p16 mutation in familial malignant melanoma in southern Sweden.
    Cancer Res. 1996 Jun 1;56(11):2497-500 PMID: 8653684
  12. Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma.
    Mol Cell Biol. 1996 Jul;16(7):3844-52 PMID: 8668202
  13. The current situation with regard to human melanoma and genetic inferences.
    Curr Opin Oncol. 1996 Mar;8(2):136-42 PMID: 8727306
  14. CDKN2 mutations in melanoma.
    Cancer Surv. 1996;26:115-32 PMID: 8783570
  15. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.
    J Natl Cancer Inst. 1997 May 21;89(10):697-702 PMID: 9168184
  16. Germline mutations of the CDKN2 gene in UK melanoma families.
    Hum Mol Genet. 1997 Nov;6(12):2061-7 PMID: 9328469
  17. Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds.
    Oncogene. 1997 Dec 11;15(24):2999-3005 PMID: 9416844
  18. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
    Hum Mol Genet. 1998 Feb;7(2):209-16 PMID: 9425228
  19. Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution.
    Ann Hum Genet. 1997 Sep;61(Pt 5):411-24 PMID: 9459003
  20. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
    Am J Hum Genet. 1998 Jun;62(6):1381-8 PMID: 9585613
  21. Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: evidence for common founders and independent mutations.
    Hum Mutat. 1998;11(6):424-31 PMID: 9603434
  22. Surnames, HLA genes and ancient migrations in the Po Valley (Italy).
    Ann Hum Genet. 1998 May;62(Pt 3):261-9 PMID: 9803270
  23. Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma.
    Nat Genet. 1999 Jan;21(1):128-32 PMID: 9916806
  24. Characterization of ligurian melanoma families and risk of occurrence of other neoplasia.
    Int J Cancer. 1999 Nov 12;83(4):441-8 PMID: 10508477
  25. New estimates of intergenerational time intervals for the calculation of age and origins of mutations.
    Am J Hum Genet. 2000 Feb;66(2):651-8 PMID: 10677323
  26. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
    J Natl Cancer Inst. 2000 Jun 21;92(12):1006-10 PMID: 10861313
  27. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
    J Med Genet. 1999 Jun;36(6):490-3 PMID: 10874641
  28. A genetic history of Italy.
    Ann Hum Genet. 1988 Jul;52(Pt 3):203-13 PMID: 3074731
  29. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Nature. 1993 Dec 16;366(6456):704-7 PMID: 8259215
  30. Inhibition of ras-induced proliferation and cellular transformation by p16INK4.
    Science. 1995 Jan 13;267(5195):249-52 PMID: 7809631
Article Info
Journal
American journal of human genetics
Abbr.
Am J Hum Genet
ISSN
0002-9297
Published
2000-08-00
Epub
2000-00-22
Pages
311-9
Language
English
Region
United States
NLM ID
0370475
PMCID
PMC1287180
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com